These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22069504)

  • 1. Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.
    Gat O; Galen JE; Tennant S; Simon R; Blackwelder WC; Silverman DJ; Pasetti MF; Levine MM
    PLoS Negl Trop Dis; 2011 Nov; 5(11):e1373. PubMed ID: 22069504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
    Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
    Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated
    Liu Q; Li P; Luo H; Curtiss R; Kong Q
    Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of Concern: Cell-Associated Flagella Enhance the Protection Conferred by Mucosally-Administered Attenuated Salmonella Paratyphi A Vaccines.
    PLOS Neglected Tropical Diseases Editors
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012160. PubMed ID: 38709719
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.
    Wahid R; Zafar SJ; McArthur MA; Pasetti MF; Levine MM; Sztein MB
    Clin Vaccine Immunol; 2014 Mar; 21(3):427-34. PubMed ID: 24429069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and protective efficacy of a Salmonella pathogenicity island 2 (SPI2) mutant of Salmonella Paratyphi A.
    Yin J; Cheng Z; Wu Y; He Q; Zhang J; Yang Z; Ding S; Li J; Guo D
    Microb Pathog; 2019 Dec; 137():103795. PubMed ID: 31610219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.
    Tennant SM; Wang JY; Galen JE; Simon R; Pasetti MF; Gat O; Levine MM
    Infect Immun; 2011 Oct; 79(10):4175-85. PubMed ID: 21807911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions in
    Fuche FJ; Jones JA; Ramachandran G; Higginson EE; Simon R; Tennant SM
    Hum Vaccin Immunother; 2019; 15(6):1427-1435. PubMed ID: 29927725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Our Understanding of
    Higginson EE; Ramachandran G; Hazen TH; Kania DA; Rasko DA; Pasetti MF; Levine MM; Tennant SM
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30487152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates.
    Roland KL; Tinge SA; Kochi SK; Thomas LJ; Killeen KP
    Vaccine; 2010 May; 28(21):3679-87. PubMed ID: 20338215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
    Das S; Chowdhury R; Pal A; Okamoto K; Das S
    Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
    Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J
    Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of host immune responses by oral vaccination to Salmonella enterica serovar Typhimurium harboring both FliC and FljB flagella.
    Eom JS; Seok Kim J; Im Jang J; Kim BH; Young Yoo S; Hyeon Choi J; Bang IS; Lee IS; Keun Park Y
    PLoS One; 2013; 8(9):e74850. PubMed ID: 24069357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective efficacy against
    Schuster O; Sears KT; Ramachandran G; Fuche FJ; Curtis B; Tennant SM; Simon R
    Hum Vaccin Immunother; 2019; 15(6):1436-1444. PubMed ID: 29873578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
    Wahid R; Simon R; Zafar SJ; Levine MM; Sztein MB
    Clin Vaccine Immunol; 2012 Jun; 19(6):825-34. PubMed ID: 22492745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of an immune evasion gene,
    Allen JC; Natta SS; Nasrin S; Toapanta FR; Tennant SM
    Front Immunol; 2024; 15():1376734. PubMed ID: 38911854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated
    Łaniewski P; Baek CH; Roland KL; Curtiss R
    mBio; 2017 Aug; 8(4):. PubMed ID: 28830946
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
    Sahastrabuddhe S; Carbis R; Wierzba TF; Ochiai RL
    Expert Rev Vaccines; 2013 Sep; 12(9):1021-31. PubMed ID: 24053396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.